Tapewire

NYSE · USD

CNMD

CONMED Corp

Export transactions ↓
Tapewire entity
4691
SEC CIK
0000816956
Parsed reports
532

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 10,000 $0.00 Strike: $19.26 $0.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · derivative · entry 17

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2020-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 8,000 $0.00 Strike: $16.46 $0.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · derivative · entry 16

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2019-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionOptions To Purchase Common Stock · Derivative 10,020 $0.00 Strike: $39.87 $0.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · derivative · entry 15

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,080

Underlying: Common Stock · 10,020 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 4,315 $53.37 $230,291.55
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 14

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,386

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 4,680 $44.90 $210,132.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 13

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 7,790 $53.37 $415,752.30
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 12

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,021

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 9,600 $32.93 $316,128.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 11

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 7,484 $53.37 $399,421.08
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 10

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,211

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 10,000 $26.09 $260,900.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 9

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 7,626 $53.37 $406,999.62
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 8

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,695

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 10,000 $27.63 $276,300.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 7

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 6,854 $53.37 $365,797.98
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 6

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,321

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 10,000 $19.26 $192,600.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 5

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Tax withholdingCommon Stock 5,277 $53.37 $281,633.49
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 4

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,175

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 8,000 $16.46 $131,680.00
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 3

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
SaleCommon Stock 10,020 $53.57 $536,771.40
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 2

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,452

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.55 to $53.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:32 UTC
POMILIO LUKE AEVP, Finance & CFO
Exercise / conversionCommon Stock 10,020 $39.87 $399,497.40
Disclosure

SEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 1

POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 2,500 $0.00 Strike: $26.69 $0.00
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · derivative · entry 6

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2018-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 2,000 $0.00 Strike: $16.46 $0.00
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · derivative · entry 5

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2019-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 1,713 $53.37 $91,422.81
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · nonDerivative · entry 4

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,908

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 2,500 $26.69 $66,725.00
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · nonDerivative · entry 3

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 1,129 $53.37 $60,254.73
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · nonDerivative · entry 2

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,121

Read SEC document
November 03, 2017 Filed Nov 7, 2017 17:14 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 2,000 $16.46 $32,920.00
Disclosure

SEC source: 0001127602-17-031436 · form4.xml · nonDerivative · entry 1

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2017 Filed Oct 27, 2017 15:35 UTC Exercise / conversionRsus (restricted Stock Units) · Derivative 560 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-030361 · form4.xml · derivative · entry 3

KENNEDY JOHN JED · CIK 0001287981 · VP GM CET

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 560 shares

Expires 2022-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.

Read SEC document
October 26, 2017 Filed Oct 27, 2017 15:35 UTC Tax withholdingCommon Stock 182 $52.89 $9,625.98
Disclosure

SEC source: 0001127602-17-030361 · form4.xml · nonDerivative · entry 2

KENNEDY JOHN JED · CIK 0001287981 · VP GM CET

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,705

Read SEC document
October 26, 2017 Filed Oct 27, 2017 15:35 UTC Exercise / conversionCommon Stock 560 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-030361 · form4.xml · nonDerivative · entry 1

KENNEDY JOHN JED · CIK 0001287981 · VP GM CET

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 03, 2017 Filed Oct 3, 2017 21:21 UTC PurchaseCommon Stock 148 $53.96 $7,986.08
Disclosure

SEC source: 0001127602-17-029013 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,549

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017.

Read SEC document
October 02, 2017 Filed Oct 2, 2017 17:53 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
GrantCommon Stock 32 $49.85 $1,595.20
Disclosure

SEC source: 0001127602-17-028561 · form4.xml · nonDerivative · entry 1

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265

Read SEC document
October 02, 2017 Filed Oct 2, 2017 17:18 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
GrantCommon Stock 84 $49.85 $4,187.40
Disclosure

SEC source: 0001127602-17-028555 · form4.xml · nonDerivative · entry 1

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,106

Read SEC document
August 14, 2017 Filed Aug 15, 2017 20:04 UTC SaleCommon Stock 3,000 $50.00 $150,000.00
Disclosure

SEC source: 0001127602-17-025637 · form4.xml · nonDerivative · entry 1

GOLDEN JO ANN · CIK 0001238330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,782

Read SEC document
July 05, 2017 Filed Jul 6, 2017 16:05 UTC PurchaseCommon Stock 157 $50.78 $7,972.46
Disclosure

SEC source: 0001127602-17-023244 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,401

F1 · price: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017.

Read SEC document
June 30, 2017 Filed Jul 3, 2017 17:16 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
GrantCommon Stock 87 $48.39 $4,209.93
Disclosure

SEC source: 0001127602-17-022506 · form4.xml · nonDerivative · entry 1

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,022

Read SEC document
June 30, 2017 Filed Jul 3, 2017 17:36 UTC
Peters Stanley W IIIVP GM Advanced Surgery
GrantCommon Stock 17 $48.39 $822.63
Disclosure

SEC source: 0001127602-17-022513 · form4.xml · nonDerivative · entry 1

Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,371

Read SEC document
June 13, 2017 Filed Jun 14, 2017 19:12 UTC
Kuyper DirkDirector
SaleCommon Stock 1,000 $52.24 $52,238.50
Disclosure

SEC source: 0001127602-17-021414 · form4.xml · nonDerivative · entry 1

Kuyper Dirk · CIK 0001404850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,739

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.17 to $52.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 4,000 $0.00 Strike: $32.93 $0.00
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · derivative · entry 6

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2023-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Exercise / conversionSars (Stock Appreciation Rights) · Derivative 2,000 $0.00 Strike: $26.09 $0.00
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · derivative · entry 5

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2022-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Tax withholdingCommon Stock 3,068 $52.26 $160,333.68
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · nonDerivative · entry 4

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,935

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Exercise / conversionCommon Stock 4,000 $32.93 $131,720.00
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · nonDerivative · entry 3

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,003

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Tax withholdingCommon Stock 1,369 $52.26 $71,543.94
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · nonDerivative · entry 2

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,003

Read SEC document
June 02, 2017 Filed Jun 5, 2017 20:14 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
Exercise / conversionCommon Stock 2,000 $26.09 $52,180.00
Disclosure

SEC source: 0001127602-17-020527 · form4.xml · nonDerivative · entry 1

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:55 UTC GrantOptions To Purchase Common Stock · Derivative 3,669 $51.90 Strike: $51.90 $190,421.10
Disclosure

SEC source: 0001127602-17-020281 · form4.xml · derivative · entry 4

Workman John L · CIK 0001302537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,669

Underlying: Common Stock · 3,669 shares

Expires 2027-06-01

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:55 UTC GrantRsus (restricted Stock Units) · Derivative 2,167 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020281 · form4.xml · derivative · entry 3

Workman John L · CIK 0001302537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,167

Underlying: Common Stock · 2,167 shares

Expires 2027-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:55 UTC Exercise / conversionRsus (restricted Stock Units) · Derivative 2,739 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020281 · form4.xml · derivative · entry 2

Workman John L · CIK 0001302537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,739 shares

Expires 2026-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:55 UTC Exercise / conversionCommon Stock 2,739 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020281 · form4.xml · nonDerivative · entry 1

Workman John L · CIK 0001302537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,239

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:52 UTC GrantOptions To Purchase Common Stock · Derivative 4,892 $51.90 Strike: $51.90 $253,894.80
Disclosure

SEC source: 0001127602-17-020275 · form4.xml · derivative · entry 4

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,892

Underlying: Common Stock · 4,892 shares

Expires 2027-06-01

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:52 UTC GrantRsus (restricted Stock Units) · Derivative 2,890 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020275 · form4.xml · derivative · entry 3

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,890

Underlying: Common Stock · 2,890 shares

Expires 2027-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:52 UTC Exercise / conversionRsus (restricted Stock Units) · Derivative 3,653 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020275 · form4.xml · derivative · entry 2

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,653 shares

Expires 2026-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:52 UTC Exercise / conversionCommon Stock 3,653 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020275 · form4.xml · nonDerivative · entry 1

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,678

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:48 UTC
Kuyper DirkDirector
GrantOptions To Purchase Common Stock · Derivative 3,669 $51.90 Strike: $51.90 $190,421.10
Disclosure

SEC source: 0001127602-17-020272 · form4.xml · derivative · entry 4

Kuyper Dirk · CIK 0001404850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,669

Underlying: Common Stock · 3,669 shares

Expires 2027-06-01

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 19:48 UTC
Kuyper DirkDirector
GrantRsus (restricted Stock Units) · Derivative 2,167 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020272 · form4.xml · derivative · entry 3

Kuyper Dirk · CIK 0001404850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,167

Underlying: Common Stock · 2,167 shares

Expires 2027-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.